These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35961579)

  • 1. Association between circulating asprosin levels and carotid atherosclerotic plaque in patients with type 2 diabetes.
    Deng X; Zhao Z; Zhao L; Wang C; Li Y; Cai Z; Li H; Gu T; Xia Y; Zhang Z; Wang D; Yang L; Yuan G
    Clin Biochem; 2022; 109-110():44-50. PubMed ID: 35961579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy.
    Goodarzi G; Setayesh L; Fadaei R; Khamseh ME; Aliakbari F; Hosseini J; Moradi N
    Mol Biol Rep; 2021 Jul; 48(7):5443-5450. PubMed ID: 34304366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Isthmin-1 is negatively correlated with HDL-C in type 2 diabetes mellitus.
    Feng RQ; Xu MY; Feng RY; Zhang L; Yin XF; Wang C; Liu JB
    J Diabetes Complications; 2023 Oct; 37(10):108567. PubMed ID: 37647712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentration of asprosin in new-onset type 2 diabetes.
    Naiemian S; Naeemipour M; Zarei M; Lari Najafi M; Gohari A; Behroozikhah MR; Heydari H; Miri M
    Diabetol Metab Syndr; 2020; 12():65. PubMed ID: 32714446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of asprosin and Nrg-4 with type 2 diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value.
    Zhong M; Tian X; Sun Q; Li L; Lu Y; Feng Z; Gao Y; Li S
    BMC Endocr Disord; 2023 Mar; 23(1):61. PubMed ID: 36915073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study.
    Cui J; Liu Y; Li M; Yin J; Yang J; Xu L
    BMC Endocr Disord; 2024 Mar; 24(1):27. PubMed ID: 38438865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus.
    Dai C; Zhu W
    Medicine (Baltimore); 2022 Oct; 101(43):e31334. PubMed ID: 36316938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Important Players for Type 2 Diabetes Mellitus: Metrnl and Asprosin.
    Timurkaan M; Timurkaan ES
    Clin Lab; 2022 Sep; 68(9):. PubMed ID: 36125157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for carotid plaque formation in type 2 diabetes mellitus.
    Chen J; Li W; Cao J; Lu Y; Wang C; Lu J
    J Transl Med; 2024 Jan; 22(1):18. PubMed ID: 38178198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride.
    Zhang L; Chen C; Zhou N; Fu Y; Cheng X
    Clin Chim Acta; 2019 Feb; 489():183-188. PubMed ID: 29104036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating asprosin concentrations in individuals with new-onset type 2 diabetes and prediabetes.
    Diao H; Fan X; Li Z; Hou L; Dong Z; Pang S
    Diabetes Res Clin Pract; 2024 Jul; 213():111730. PubMed ID: 38866185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating asprosin, irisin, and abdominal obesity in Chinese patients with type 2 diabetes mellitus: a case-control study.
    Hu G; Si W; Zhang Q; Lv F
    Endokrynol Pol; 2023; 74(1):55-62. PubMed ID: 36537187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases.
    Li X; Liao M; Shen R; Zhang L; Hu H; Wu J; Wang X; Qu H; Guo S; Long M; Zheng H
    Mediators Inflamm; 2018; 2018():7375294. PubMed ID: 30524197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease.
    You M; Liu Y; Wang B; Li L; Zhang H; He H; Zhou Q; Cao T; Wang L; Zhao Z; Zhu Z; Gao P; Yan Z
    Cardiovasc Diabetol; 2022 Feb; 21(1):25. PubMed ID: 35168605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes.
    Deng X; Zhao L; Guo C; Yang L; Wang D; Li Y; Xia H; Wang C; Cai Z; Li L; Zhao Z; Yuan G
    Diabetes Metab Syndr Obes; 2020; 13():4341-4351. PubMed ID: 33223841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of serum asprosin level with diabetic and non-diabetic retinopathy.
    Atlı H; Onalan E; Yakar B; Kaymaz T; Duzenci D; Karakulak K; Dönder E; Gürsu MF; Dayanan R
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2117-2123. PubMed ID: 35363361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium-glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus.
    Jiang A; Feng Z; Yuan L; Zhang Y; Li Q; She Y
    Diabetol Metab Syndr; 2021 Mar; 13(1):34. PubMed ID: 33766125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes.
    Yoo HJ; Hwang SY; Hong HC; Choi HY; Yang SJ; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH
    Cardiovasc Diabetol; 2011 Nov; 10():103. PubMed ID: 22108456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum asprosin is correlated with diabetes mellitus-induced erectile dysfunction.
    Li CH; Zhao X; Xu Y; Zhang F; Li CT; Zhao SN; Hao YM
    Diabetol Metab Syndr; 2024 Apr; 16(1):91. PubMed ID: 38659035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.